Carregant...
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy
Recent advances in cancer biology and genetics have fostered precision therapies targeting tumor-specific attributes. Immune-based therapies that elicit cytolytic T cells (CTL) specific for tumor antigens can provide therapeutic benefit to cancer patients, however, cure rates are typically low. This...
Guardat en:
| Publicat a: | Immunotherapy |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5619014/ https://ncbi.nlm.nih.gov/pubmed/28000531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2016-0097 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|